ATXN10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.65401026208656E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.13762382531513E-13 |
Normal-vs-Stage2 |
1.80588877185528E-12 |
Normal-vs-Stage3 |
1.62481139653892E-12 |
Normal-vs-Stage4 |
3.98570065840431E-14 |
Stage1-vs-Stage2 |
1.420440E-01 |
Stage1-vs-Stage3 |
1.221610E-04 |
Stage1-vs-Stage4 |
7.180500E-02 |
Stage2-vs-Stage3 |
1.599780E-01 |
Stage2-vs-Stage4 |
7.829200E-01 |
Stage3-vs-Stage4 |
2.395600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.4980018054066E-14 |
Normal-vs-AfricanAmerican |
7.71493979812021E-13 |
Normal-vs-Asian |
3.88590000000022E-05 |
Caucasian-vs-AfricanAmerican |
7.423400E-01 |
Caucasian-vs-Asian |
7.979800E-01 |
AfricanAmerican-vs-Asian |
7.034600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62980740014973E-12 |
Normal-vs-Female |
1.32982513889601E-12 |
Male-vs-Female |
2.183500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.42949999510012E-08 |
Normal-vs-Age(41-60Yrs) |
5.62883073484954E-14 |
Normal-vs-Age(61-80Yrs) |
1.65611968583335E-12 |
Normal-vs-Age(81-100Yrs) |
3.61930485581752E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.623800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.200400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.002800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.707200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.154600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.137000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.03479999999679E-06 |
Normal-vs-Grade 2 |
2.51265674933165E-12 |
Normal-vs-Grade 3 |
1.6286971771251E-12 |
Normal-vs-Grade 4 |
1.11022302462516E-16 |
Grade 1-vs-Grade 2 |
1.462410E-01 |
Grade 1-vs-Grade 3 |
1.506000E-02 |
Grade 1-vs-Grade 4 |
2.699000E-03 |
Grade 2-vs-Grade 3 |
3.078300E-03 |
Grade 2-vs-Grade 4 |
1.447690E-04 |
Grade 3-vs-Grade 4 |
1.056440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.49174031302846E-12 |
Normal-vs-ccB subtype |
1.62614366416847E-12 |
ccA subtype-vs-ccB subtype |
1.393950E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.72095671047146E-12 |
Normal-vs-N1 |
1.625350E-04 |
N0-vs-N1 |
8.732800E-01 |
|
|